06.12.26 -- What Reliance, Annex 1, And AI Mean For The Future Of GMP

Manual records create unnecessary compliance risks. Learn how digital systems provide the automated version control and traceability required to meet modern regulatory expectations and audits.

Shift from basic compliance to a strategic GxP culture. Explore how intentional, role-specific training and leadership support reduce risks and improve business outcomes in this video.

Inspection‑readiness depends on consistency and control. Examine strategies for standardizing cell sorting workflows, minimizing variability, and using electronic records to support compliance.

In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

Translating EU GMP Annex 1 into consistent site-level practice is where most manufacturers struggle. Hear why the global-to-local execution gap remains the industry's biggest compliance challenge.

In times of uncertainty, collaboration becomes a strategic advantage. Find out how leading organizations can leverage collective expertise to navigate complexity, drive innovation, and build resilience.

OEE provides a high-level view of equipment performance, but it doesn’t explain the root causes. See why manufacturers need deeper insight to turn utilization metrics into meaningful improvements.

Automated microscopy is helping teams move faster with more consistent imaging. Uncover how high-throughput systems reduce variability, support digital workflows, and strengthen decision-making.

In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.

Discover how to determine the linear range for western blot quantification using total protein stains or housekeeping proteins to ensure accurate normalization and avoid saturation effects.

Gain insight into where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.

Phosphorylation is key for bioactives, with phosphoramidites favored for high selectivity. Delve into how choosing specific protecting groups and new technologies fine-tunes the synthesis process.

Transitioning from periodic testing to continuous monitoring is essential for modern aseptic safety. Take a look at how real-time particle tracking mitigates risk and ensures compliance.

Technology transfer succeeds through trust, shared knowledge, and disciplined execution. Read about how collaboration, strong documentation, and digital tools reduce risk on the path to GMP.

Observe a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.

Examine how a molecular genetics team improves NGS efficiency and library quality through streamlined automation, intuitive QC tools, and reliable workflows, boosting reproducibility.

Explore how to strengthen peptide bioanalysis, from improving recovery and reducing non‑specific binding to optimizing LC‑MS sensitivity and streamlining data review to achieve reliable quantification.

Watch how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding.

Review chromatography fundamentals, resin selection strategies, and the regulatory frameworks required to qualify automated systems for compliant, commercial-scale biologics manufacturing.

True digital twins are redefining pharmaceutical manufacturing. Learn key distinctions, GMP-aligned frameworks, and real-world applications in predictive quality, CPV, and intelligent optimization.

High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.

Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Find out how to overcome the challenges in the characterization process.

Reveal the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.